125 related articles for article (PubMed ID: 9073026)
1. Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease.
Merched A; Blain H; Visvikis S; Herbeth B; Jeandel C; Siest G
J Neurol Sci; 1997 Jan; 145(1):33-9. PubMed ID: 9073026
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease.
Fukuyama R; Mizuno T; Mori S; Yanagisawa K; Nakajima K; Fushiki S
Eur Neurol; 2000; 43(3):161-9. PubMed ID: 10765057
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease.
Lehtimäki T; Pirttilä T; Mehta PD; Wisniewski HM; Frey H; Nikkari T
Hum Genet; 1995 Jan; 95(1):39-42. PubMed ID: 7814023
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E levels in the cerebrospinal fluid of north Indian patients with Alzheimer's disease.
Kandimalla RJ; Wani WY; Anand R; Kaushal A; Prabhakar S; Grover VK; Bharadwaj N; Jain K; Gill KD
Am J Alzheimers Dis Other Demen; 2013 May; 28(3):258-62. PubMed ID: 23612909
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
6. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease.
Arai H; Higuchi S; Sasaki H
Gerontology; 1997; 43 Suppl 1():2-10. PubMed ID: 9187933
[TBL] [Abstract][Full Text] [Related]
9. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
10. Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.
Bekris LM; Millard SP; Galloway NM; Vuletic S; Albers JJ; Li G; Galasko DR; DeCarli C; Farlow MR; Clark CM; Quinn JF; Kaye JA; Schellenberg GD; Tsuang D; Peskind ER; Yu CE
J Alzheimers Dis; 2008 Apr; 13(3):255-66. PubMed ID: 18430993
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
12. Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.
Gabriel AJ; Almeida MR; Ribeiro MH; Durães J; Tábuas-Pereira M; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
Neurosci Lett; 2017 Feb; 641():101-106. PubMed ID: 28108398
[TBL] [Abstract][Full Text] [Related]
13. Measurement of apolipoprotein E (apoE) in cerebrospinal fluid.
Hesse C; Larsson H; Fredman P; Minthon L; Andreasen N; Davidsson P; Blennow K
Neurochem Res; 2000 Apr; 25(4):511-7. PubMed ID: 10823584
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform.
Landén M; Hesse C; Fredman P; Regland B; Wallin A; Blennow K
Dementia; 1996; 7(5):273-8. PubMed ID: 8872419
[TBL] [Abstract][Full Text] [Related]
15. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.
Fagan AM; Younkin LH; Morris JC; Fryer JD; Cole TG; Younkin SG; Holtzman DM
Ann Neurol; 2000 Aug; 48(2):201-10. PubMed ID: 10939571
[TBL] [Abstract][Full Text] [Related]
16. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease.
Cruchaga C; Kauwe JS; Nowotny P; Bales K; Pickering EH; Mayo K; Bertelsen S; Hinrichs A; ; Fagan AM; Holtzman DM; Morris JC; Goate AM
Hum Mol Genet; 2012 Oct; 21(20):4558-71. PubMed ID: 22821396
[TBL] [Abstract][Full Text] [Related]
18. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.
Blennow K; Hesse C; Fredman P
Neuroreport; 1994 Dec; 5(18):2534-6. PubMed ID: 7696597
[TBL] [Abstract][Full Text] [Related]
20. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
